EST Cathie Wood’s ARK Investment buys 187K shares of Crispr Therapeutics (CRSP) todayMaximize Your Portfolio with Data Driven ...

Legendary fund manager Cathie Wood isn’t typically associated with boring, dividend-paying companies. Known for picking up ...

Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared ...

Low-cost passive index investing (in the S&P 500 or Nasdaq 100) has been key to impressive results in recent years. However, with much of the outsized gains coming from just a handful of names (at the ...

Explore Cathie Wood's latest investment insights on the convergence of artificial intelligence in shaping the future, as ...

As of 1:10 p.m. ET today, the price of Ethereum ( ETH -4.21%), the world's second-largest cryptocurrency, traded 4.2% higher from late afternoon yesterday. Meanwhile, the price of the meme tokens ...

LOS ANGELES, Feb. 5, 2025 /PRNewswire/ -- Abundance360 (A360), the premier leadership community for exponential entrepreneurs ...

Noting that Ambry is a profitable testing laboratory that generates more than $300 million of revenue annually, the investment bank thinks that the deal will enable TEM to start generating positive ...

Catherine Wood ( Trades, Portfolio) also increased stakes in a total of 52 stocks, among them: ...

BlackRock(NYSE: BLK) oversees more than $11.6 trillion worth of client money, making it the largest asset manager in the ...

Feb. 4, 2025, Cathie Wood-led Ark Invest dumped $7.4 million worth of Palantir stock even as the shares rose 24% over ...

Cathie Wood says most profound application of AI is in healthcare. She particularly expects Recursion Pharma and Illumina to ...